Get started
Author

Abdul Mussa

Institution: Malaria Consortium
ORCID: 0000-0002-4736-3031
Observed ORCID: 0000-0002-4736-3031
OpenAlex ID: A5084453359
Five Years of Antimalarial Resistance Marker Surveillance in Gaza Province, Mozambique, Following Artemisinin-Based Combination Therapy Roll Out
2011 · Jaishree Raman, Katya Mauff, et al. · PLoS ONE · 44
PDF
In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique
2014 · Abel Nhama, Quique Bassat, et al. · Malaria Journal · 32
PDF
Virologic Outcomes and ARV Switch Profiles 2 Years After National Rollout of Dolutegravir to Children Less Than 15 Years in Southern Mozambique
2023 · Michelle M. Gill, Nicole Herrera, et al. · The Pediatric Infectious Disease Journal · 12
The rollout of paediatric dolutegravir and virological outcomes among children living with HIV in Mozambique
2024 · Ivete Meque, Nicole Herrera, et al. · Southern African Journal of HIV Medicine · 6
Lessons from using SALAMA (DIGIT HCM—health campaign management platform) to implement and optimize seasonal malaria chemoprevention in Nampula, Mozambique
2026 · Abdul Mussa, Maria Rodrigues, et al. · Oxford Open Digital Health · 2
PDF
Digital transformation of campaign delivery: a mixed-methods costing and efficiency analysis from Mozambique's seasonal malaria chemoprevention programme
2026 · Bryony Simmons, Neide Canana, et al. · The Lancet Regional Health - Africa
Zero-Dose Identification and Reach Using Electronic Community Health Records in Mozambique: a type 2 hybrid effective-ness-implementation study protocol (Preprint)
2025 · Ivan Alejandro Pulido Tarquino, Chukwudi A. Nnaji, et al.
Assessment of the effect of Intermittent Preventive Treatment of malaria in pregnancy on birth weight of babies in Nigeria: a life-saving dynamics
2016 · Yetunde Oke, Muhammad Salihu, et al.
Works count: 9
Citation count: 96
H-index: 4
I10-index: 3
Year
Topic
Type